Drug Eluting Stent (DES) is a drug-device combination product. It is a metal stent coated with a pharmacological agent (drug). The drug interferes with the process of restenosis and prevents the reblocking of the artery. DES has been shown to reduce the incidence of restenosis from 20–30% range to single digits. A polymer is usually mixed -in with the drug to control the release of the drug into the vessel wall.
Drug Eluting Stents: A New Class of Combination Product
- Views Icon Views
- Share Icon Share
- Search Site
Dutta, D. "Drug Eluting Stents: A New Class of Combination Product." Proceedings of the ASME 2007 2nd Frontiers in Biomedical Devices Conference. ASME 2007 2nd Frontiers in Biomedical Devices. Irvine, California, USA. June 7–8, 2007. pp. 47-48. ASME. https://doi.org/10.1115/BioMed2007-38044
Download citation file: